top of page

Suspension of Admissions

TTI has suspended admissions into Allentown Residential. Read more below from our Executive Director.

Phase One

Residents become stabilized & acclimated to the program as they meet with staff & receive an individualized treatment plan to best suit their goals & needs. 

Phase Two

Residents gain insight into healthy communication & recovery-based support by becoming reengaged into the community & working towards strengthening relationships with family.

Phase Three

Residents are provided with the necessary support & guidance to prevent relapse as they prepare to transition into the next level of care after program completion.

Residential Support

Allentown Residential

18 S. 6th Street

Allentown, PA 18101

Phone: 610-439-8479

Fax: 610-289-1833 

Referrals: residential@treatmenttrends.org

TTI Residential

This is a paragraph about your business. Let your visitors know who you are, what you do and what your website is all about. Double click on the text box to edit the text and add all the information you want to share.

The treatment provided at Allentown Residential reflects the ASAM criteria and DDAP designation for Level 3.5 clinically managed high intensity residential services.

TTI Allentown Residential is a progress based residential program that focuses on mental health in relation to addiction and substance use disorder. Our goal is to help individuals by creating treatment plans where we assist them in reaching their desired goals and aid in their recovery. Our program operates in three phases: Stabilization, Communication & Support, and Relapse Prevention. These three phases offer different levels of support with the goal of completing the program and transitioning into the next level of treatment on a strong, stable pathway to recovery. 

 

Residents are required to complete 6-8 hours of treatment/recovery themed activities each day.

Allentown Residential is a non-smoking facility, where residents are given designated smoke breaks each day.

We offer multiple forms of MAT, including:  oral naltrexone, extended release naltrexone (Vivitrol), extended release buprenorphine (Sublocade) and buprenorphine-naloxone products (such as Suboxone and Zubsolv).

We accept Medicaid & County Funded insurance.

bottom of page